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ASTRACT 
  
The aim of the study was to evaluate the effect of the trigonella 
foenum garaecum seeds powder (TSP) on lipid profile in cholesterol fed 
rat  
Twenty Wistar albino rats were divided into four groups named A, 
B, C and D of five rats each. Group A was given the basal diet and served 
as control, group B was given basal diet and 1% cholesterol added to the 
basal diet, group C was given basal diet and 1% cholesterol and 4% TSP 
added to the basal diet and group D was given basal diet and 1% 
cholesterol and 8% TSP added to the basal diet for four weeks.  
Blood samples were collected from group A and B after two weeks 
so as to confirm    the induction of hypercholesterolemia. The level of 
total cholesterol and LDL-c was significantly (P› 0.05) increased in group 
B compared to the control whereas, the level of HDL-c were significantly 
(P› 0.05) decreased in group B compared to the control. 
Blood samples were collected from all groups after four weeks. 
The level of total cholesterol and LDL-c was significantly (P› 0.05) 
decreased in group C and D    compared to group B. while the level not 
significantly different in group C, and D compared to group B. the level 
of HDL-c were significantly (P› 0.05) decreased in group C and D 
compared to B. there was non- significant difference in the levels of total 
cholesterol, LDL-c, HDL-c and triglycerides in group C and D compared 
to the control group.  
 
 
 
 
 
 
  اﻟﻤﻠﺨﺺ اﻟﻌﺮﺑﻲ
هﺪﻓﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻟﺘﻘﻴﻢ ﺑﺬور اﻟﺤﻠﺒﻪ اﻟﻤﺴﺤﻮﻧﺔ ﻋﻠѧﻲ ﻣﺴѧﺘﻮي اﻟѧﺪهﻮن ﻓѧﻲ اﻟﻔﺌѧﺮان اﻟﻤﻐﺬﻳѧﻪ إﺿѧﺎﻓﻴﺎ 
  .ﺑﺎﻟﻜﻮﻟﺴﺘﺮول
. آѧﻞ ﻣﺠﻤﻮﻋѧﻪ ﺗﺤﺘѧﻮي ﻋﻠѧﻲ ﺧﻤѧﺲ ﻓﺌѧﺮان . ج و د، ب، ﻋﺸﺮون ﻓﺄرا ﻗﺴﻤﻮا اﻟﻲ أرﺑﻊ ﻣﺠﻤﻮﻋﺎت أ
(  ب)اﻟﻤﺠﻤﻮﻋѧѧﺔ ، هѧѧﻲ ﻣﺠﻤﻮﻋѧѧﻪ اﻟѧѧﺘﺤﻜﻢ و أﻋﻄﻴѧѧﺖ اﻟﻮﺟﺒѧѧﺔ اﻷﺳﺎﺳѧѧﻴﺔ ( أ)ﺣﻴѧѧﺚ آﺎﻧѧѧﺖ اﻟﻤﺠﻤﻮﻋѧѧﻪ 
أﻋﻄﻴѧﺖ اﻟﻮﺟﺒѧﺔ اﻷﺳﺎﺳѧﻴﺔ  (  ج)اﻟﻤﺠﻤﻮﻋѧﺔ ، آﻮﻟﻴﺴѧﺘﺮول% 1أﻋﻄﻴѧﺖ اﻟﻮﺟﺒѧﺔ اﻷﺳﺎﺳѧﻴﺔ  ﺑﺈﺿѧﺎﻓﺔ 
أﻋﻄﻴѧѧﺖ (  د)اﻣѧѧﺎ اﻟﻤﺠﻤﻮﻋѧѧﺔ %  4آﻮﻟﻴﺴѧѧﺘﺮول  و ﺑѧѧﺬور اﻟﺤﻠﺒѧѧﺔ اﻟﻤﺴѧѧﺤﻮﻧﺔ ﻳﻨﺴѧѧﺒﺔ % 1ﺑﺈﺿѧѧﺎﻓﺔ 
أرﺑﻌѧѧﺔ  ﻟﻤѧѧﺪة  %8آﻮﻟﻴﺴѧѧﺘﺮول و ﺑѧѧﺬور اﻟﺤﻠﺒѧѧﺔ اﻟﻤﺴѧѧﺤﻮﻧﺔ ﻳﻨﺴѧѧﺒﺔ % 1اﻟﻮﺟﺒѧѧﺔ اﻷﺳﺎﺳѧѧﻴﺔ  ﺑﺈﺿѧѧﺎﻓﺔ 
  .ﺎﺑﻴﻊاﺳ
اﻟﻤﺠﻤﻮﻋѧﺔ و (  أ) اﻟﻤﺠﻤﻮﻋѧﺔأﺧѧﺬت ﻋﻴﻨѧﺎت ﻣѧﻦ ﻣﺼѧﻞ اﻟѧﺪم ﺑﻌѧﺪ أﺳѧﺒﻮﻋﻴﻦ ﻣѧﻦ ﺑﺪاﻳѧﻪ اﻟﻤﻌﺎﻟﺠѧﺔ ﻣѧﻦ 
ﻣﺴѧѧﺘﻮﻳﺎت اﻟﻜﻮﻟﻴﺴѧѧﺘﺮول اﻟﻜﻠѧѧﻲ وآﻮﻟﻴﺴѧѧﺘﺮول اﻟﻼﺑѧѧﻮﺑﺮوﺗﻴﻦ ﻣѧѧﻨﺨﻔﺾ اﻟﻜﺜﺎﻓѧѧﺔ زادت زﻳѧѧﺎدة . (ب)
ﺑﻴﻨﻤѧﺎ آﻮﻟﻴﺴѧﺘﺮول اﻟﻼﻳﺒѧﻮ ، ﺑﺎﻟﻤﻘﺎرﻧѧﺔ ﻣѧﻊ ﻣﺠﻤﻮﻋѧﺔ اﻟѧﺘﺤﻜﻢ ( ب)ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ  )50.0 ›P(ﻣﻌﻨﻮﻳﺔ 
ﺑﺎﻟﻤﻘﺎرﻧѧѧﺔ ﻣѧѧﻊ ( ب)اﻟﻤﺠﻤﻮﻋѧѧﺔ  )50.0 ›P(ﺑѧѧﺮوﺗﻴﻦ ﻋѧѧﺎﻟﻲ اﻟﻜﺜﺎﻓѧѧﺔ إﻧﺨﻔѧѧﺾ إﻧﺨﻔﺎﺿѧѧﺎ ﻣﻌﻨﻮﻳѧѧﺎ ﻓѧѧﻲ 
  .ﻣﺠﻤﻮﻋﺔ اﻟﺘﺤﻜﻢ
ﻣﺴѧﺘﻮﻳﺎت اﻟﻜﻮﻟﻴﺴѧﺘﺮول . أﺧﺬت ﻋﻴﻨﺎت ﻣﻦ ﻣﺼﻞ اﻟﺪم ﺑﻌѧﺪ أرﺑﻌѧﺔ أﺳѧﺎﺑﻴﻊ ﻣѧﻦ آѧﻞ اﻟﻤﺠﻤﻮﻋѧﺎت      
ﻓѧﻲ اﻟﻤﺠﻤﻮﻋѧﺔ  )50.0 ›P(ﺴﺘﺮول اﻟﻼﺑﻮﺑﺮوﺗﻴﻦ ﻣﻨﺨﻔﺾ اﻟﻜﺜﺎﻓﺔ زادت زﻳѧﺎدة ﻣﻌﻨﻮﻳѧﺔ اﻟﻜﻠﻲ وآﻮﻟﻴ
ﺑﻴﻨﻤѧѧѧﺎ ﻟѧѧѧﻢ ﻳﻜѧѧѧﻦ هﻨѧѧѧﺎك ﻓѧѧѧﺮق ﻣﻌﻨѧѧѧﻮي ﻓѧѧѧﻲ ﻣﺴѧѧѧﺘﻮي ، (ب)ﺑﺎﻟﻤﻘﺎرﻧѧѧѧﻪ ﻣѧѧѧﻊ اﻟﻤﺠﻤﻮﻋѧѧѧﺔ ( د)و ( ج)
ﻣﺴѧѧѧﺘﻮي ، (ب)ﺑﺎﻟﻤﻘﺎرﻧѧѧѧﺔ ﻣѧѧѧﻊ اﻟﻤﺠﻤﻮﻋѧѧѧﺔ ( د)و ( ج)اﻟﺠﻠﻴﺴѧѧѧﺮﻳﺪات اﻟﺜﻼﺛﻴѧѧѧﺔ ﻓѧѧѧﻲ اﻟﻤﺠﻤѧѧѧﻮﻋﺘﻴﻦ 
( د)و ( ج)ﻓѧѧﻲ اﻟﻤﺠﻤѧѧﻮﻋﺘﻴﻦ   )50.0 ›P(ﻟﻜﺜﺎﻓѧѧﺔ زاد ﻣﻌﻨﻮﻳѧѧﺎ آﻮﻟﻴﺴѧﺘﺮول اﻟﻼﻳﺒѧѧﻮ ﺑѧѧﺮوﺗﻴﻦ ﻋѧѧﺎﻟﻲ ا 
ﻓѧѧﻲ ﻣﺴѧѧﺘﻮﻳﺎت اﻟﻜﻮﻟﻴﺴѧѧﺘﺮول اﻟﻜﻠѧѧﻲ وآﻮﻟﻴﺴѧѧﺘﺮول اﻟﻼﺑѧѧﻮﺑﺮوﺗﻴﻦ ، (ب)ﺑﺎﻟﻤﻘﺎرﻧѧѧﺔ ﻣѧѧﻊ اﻟﻤﺠﻤﻮﻋѧѧﺔ 
ﻣﻨﺨﻔﺾ اﻟﻜﺜﺎﻓﺔ و آﻮﻟﻴﺴﺘﺮول اﻟﻼﻳﺒﻮ ﺑﺮوﺗﻴﻦ ﻋﺎﻟﻲ اﻟﻜﺜﺎﻓﺔ و اﻟﺠﻠﻴﺴѧﺮﻳﺪات اﻟﺜﻼﺛﻴѧﺔ ﻟѧﻢ هﻨѧﺎك ﻓѧﺮق 
  .    ﻘﺎرﻧﺔ ﻣﻊ ﻣﺠﻤﻮﻋﺔ اﻟﺘﺤﻜﻢﺑﺎﻟﻤ( د)و ( ج)ﻣﻌﻨﻮي ﻓﻲ اﻟﻤﺠﻤﻮﻋﺘﻴﻦ 
 
 INTRODUCTION 
 
Lipids play many roles in biological systems. Like carbohydrates they are 
an important source of energy. In addition, they are essential components of 
membranes, they function as hormones, and they can serve as padding and 
thermal insulator.  Lipids are complex and heterogeneous groups of compounds 
that they defy rational classification.  However, despite their difference in 
structure, they share the property of being insoluble in water. Indeed they are so 
insoluble that they require special water-soluble lipid-protein complex 
(lipoprotein) for transport in the blood stream (Murray et al., 2003). 
Dyslipidaemia, which can range from hypercholesterolemia to hyper 
lipoproteinemia, is one of the many modifiable risk factors for coronary artery 
disease (CAD), stroke and peripheral vascular disease (Chong and 
Bachenheimer, 2000). Atherosclerosis is a disease of the intima of large and 
medium-sized arteries. Prominent among resultant intimal changes is the focal 
accumulation of lipid, particularly cholesterol and cholesteryl esters, in fibro fatty 
plaques known as atheromas (WHO, 1958). The atheromas narrow the arterial 
lumen, damage the underlying media and frequently become ulcerated and/or 
calcified, thus further narrowing the arterial lumen. In humans, this disease most 
commonly affects the abdominal aorta, coronary, iliac, femoral and cerebral 
arteries (Wissler, 1980). 
The use of spices as food additive has been practiced widely since ancient 
times. A part from enhancing the taste and flavour of food, spices have been 
widely believed to exert digestive stimulant action. A few medicinal properties of 
spices such as tonic, carminative, diuretic, and antispasmodic effects have long 
been recognized. These attributes are largely empirical, nevertheless efficacious, 
have earned their pharmacological applications in the indigenous systems of 
medicine as digestive stimulants and to relieve digestive disorders (Petit et al., 
1995).  
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Fenugreek (Trigonella foenum graecum) natively known as Hulabah is 
one of the oldest medicinal plant, originating in India and Northern Africa. As a 
seasonal plant, fenugreek grows to an average height of two feet. The leaves and 
seeds, which mature in long pods, are used to prepare extracts or powders for 
medicinal uses (Morcos et al., 1981). 
Fenugreek seeds have been shown to have hypoglycaemic and 
anticholesterolemic actions (Sharma, 1996). Fenugreek fed to rats of both sex at 
dietary doses of 0%, 1%, 5% and 10% in a pure diet had no effect on either the 
daily food intake or growth (Muralidhara et al.,   2000).  
There are many chemical drugs such as: statins, ezetimibe and nicotinic 
acid that lower blood cholesterol level but are most expensive and have many 
undesirable effects (Thomas, 2003). Many herbal plants that lower cholesterol 
concentration were studied by Prasanna (2000), El- Dakhakhny et al. (2000) and 
Sen and Bhattacharyya (2001). 
Parallel with recent increasing interest in alternative/herbal medicine for 
the prevention and treatment of various illnesses including hypercholesterolemia 
and because fenugreek is used daily by many Sudanese people with tea, therefore 
the aim of this study is to evaluate the effect of feeding Trigonella foenum 
graecum seeds powder (TSP) mixed diet on the level of serum lipid profile in an 
induced hypercholesterolemic Wistar albino rats. The parameters to be measured 
include serum total cholesterol, low density lipoprotein cholesterol (LDL-c), high 
density lipoprotein cholesterol (HDL-c) and triacylglycerol.  
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CHAPTER ONE 
 
LITERATURE REVIEW 
1.1. Lipids:  
Plasma lipids are derived from food (exogenous) or are synthesized in the 
body (endogenous). Lipids are relatively insoluble in water; they are carried in 
body fluids as soluble protein complexes known as lipoproteins (Murray et al., 
2003). 
 Four main classes of lipids can be recognized, from a metabolic stand 
point. These are cholesterol and its esters, triglycerides, phospholipids and fatty 
acids (Forrester et al., 1987). An understanding of the pathophysiology of plasma 
lipid metabolism is based on the concept of lipoproteins, the form in which lipids 
circulate in plasma. The principle functions of lipids are to act as energy stores 
and to serve as important structural component of cells. To fulfill these functions, 
lipids have to be transported in plasma from one tissue to another, from the 
intestine or the liver to other tissues such as muscular or adipose tissue, or from 
the other tissues to the liver (Bishop et al., 2000). There are complex mechanisms 
that control the release of lipids from tissues into plasma, and the uptake of lipids 
by the tissues from the plasma. Abnormalities of these mechanisms may be 
associated with the development of disease, particularly ischemic heart disease 
(Champe and Harvey, 1994). 
1.1.1 Cholesterol: 
Cholesterol is a lipid found in the cell membrane of all animal tissues, and 
it is transported in the blood plasma of all animals. Cholesterol is also a sterol (a 
combination of steroid and alcohol). Because cholesterol is synthesize by all 
eukaryotes. Most of the cholesterol is synthesized by the body and some has 
dietary origin. Cholesterol is more abundant in tissues which either synthesize 
more or have more abundant densely-packed membrane, for example, the liver, 
spinal cord and brain. It plays a central role in many biochemical processes, such 
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as the composition of cell membrane and the synthesis of steroid hormones 
(Stryer, 1995).  
Cholesterol from the liver and intestine is transported in plasma. About 
75% esterified with fatty acids and the rest unesterified. It is taken up from 
plasma by different tissues. Its main route of metabolism is to bile acids, which 
are secreted into bile as conjugated with glycine or taurine. Unesterified 
cholesterol is also secreted into bile, and both undergo an entero-hepatic-
circulation with some loss of cholesterol and bile acids occur daily in the faeces. 
Unlike that of triglycerides, plasma concentration of cholesterol does not rise 
after a fatty meal (Johnson et al., 1991). 
Since cholesterol is insoluble in blood, it is transported in the circulatory 
system within lipoproteins. Complex spherical particles which have an exterior 
composed mainly of water-soluble proteins; fats and cholesterol are carried 
internally (Brunzell et al., 2008).  
1.1.2. Lipoproteins: 
Lipoproteins are complexes of lipids and proteins held together by non-
covalent bonds. The core is of insoluble (non-polar) cholesterol esters and 
triglycerides, surrounded by proteins (known as apolipoproteins), phospholipids 
and free cholesterol with their water soluble (polar) groups facing outwards. 
Clinically, the most important are the lipoproteins of the plasma, which function 
as major transporters of lipids. Lipoproteins are classified based on their density 
to five fractions including high density lipoproteins (HDL), low density 
lipoproteins (LDL), intermediate density lipoproteins (IDL), very low density 
lipoproteins (VLDL) and chylomicrones (Davidson and Sittman, 1994). 
Chylomicrones are derived from the intestinal absorption of triglycerides. 
The VLDL is synthesized in the liver for exportation of triglycerides to the extra-
hepatic tissues; LDL is the final stage in the catabolism of VLDL; IDL is a 
transient lipoprotein formed during the conversion of VLDL to LDL, it contains 
both triglycerides and cholesterol, IDL is usually undetectable in normal plasma 
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(Zilva et al., 1994). HDL is involved in VLDL and chylomicrones metabolism 
and also in the transport of cholesterol to the liver (Murry et al., 2003).        
1.1.2.1 Low-density lipoprotein (LDL): 
Low-density lipoprotein (LDL) is a lipoprotein that transports cholesterol 
and triglycerides from the liver to peripheral tissues. LDL also regulates 
cholesterol synthesis at these sites. It commonly appears in the medical setting as 
part of a cholesterol blood test, and since high levels of LDL-cholesterol can 
signal medical problems like cardiovascular disease, it is sometimes called "bad 
cholesterol". Each native LDL particle contains a single apolipoprotein B-100 
molecule (Apo B-100, a protein with 4536 amino acid residues) that circulates 
the fatty acids, keeping them soluble in the aqueous environment. In addition, 
LDL has a highly-hydrophobic core consisting of polyunsaturated fatty acid 
known as linoleate and about 1500 esterified cholesterol molecules (Segrest et 
al., 2001). Conditions with elevated concentrations of oxidized LDL particles, 
especially "small dense LDL" (sdLDL) particles, are associated with atheroma 
formation in the walls of arteries, a condition known as atherosclerosis, which is 
the principal cause of coronary heart disease and other forms of cardiovascular 
disease (Lewington et al., 2007). 
1.1.2.2. High-density lipoprotein (HDL): 
HDL is the smallest of the lipoproteins. It is involved in the transport of 
cholesterol from the peripheral tissues to the liver. They are the densest because 
they contain the highest proportion of protein. They contain the A class of 
apolipoproteins. The liver synthesizes these lipoproteins as complexes of 
apolipoproteins and phospholipid, which resemble cholesterol-free flattened 
spherical lipoprotein particles. They are capable of picking up cholesterol, carried 
internally, from cells they interact with. A plasma enzyme called lecithin-
cholesterol acyltransferase (LCAT) converts the free cholesterol into cholesteryl 
ester (a more hydrophobic form of cholesterol) which is then sequestered into the 
core of the lipoprotein particle eventually making the newly synthesized HDL 
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spherical (Kwiterovich, 2000). They increase in size as they circulate through the 
bloodstream and incorporate more cholesterol molecules into their structure. 
High concentrations of functional HDL, which can remove cholesterol from cells 
and atheroma, offer protection against atherosclerosis hence termed good 
cholesterol (Durrington, 2003).   
1.1.3 Triglycerides: 
Triglycerides are fatty acid esters of glycerol, each containing three fatty 
acids. They are transported as lipoproteins from the intestine and the liver to 
various tissues, such as adipose tissue. Following hydrolysis, fatty acids are taken 
up, re-esterified and stored as triglycerides. Plasma triglyceride concentrations 
rise after a fatty meal and remain increased for several hours (Stein and Gary, 
1994). Triglycerides are absorbed from the jejunum and transferred into the 
intestinal lymph and then to the systemic circulation. Liver and intestine are also 
the major sites of triglycerides synthesis. Those formed in the liver, normally 
being secreted into plasma, and those in adipose tissue are either stored locally or 
reconverted to fatty acids and glycerol prior to re-entry into the circulation. They 
are important storage forms of energy (Whitby et al., 1987). 
1.1.4. Atherosclerosis and coronary heart disease (CDH): 
According to the lipid hypothesis, abnormally high cholesterol levels 
(hypercholesterolemia), or, more correctly, higher concentrations of low density 
lipoprotein cholesterol (LDL-c) and lower concentrations of functional high 
density lipoprotein cholesterol (HDL-c) are strongly associated with 
cardiovascular disease because these promote atheroma development in arteries 
(atherosclerosis). This disease process leads to myocardial infarction (heart 
attack), stroke and peripheral vascular disease. Since higher blood LDL-c, 
especially higher LDL-c particle concentrations and smaller LDL-c particle size, 
contribute to this process more than the cholesterol content of the LDL-c 
particles (Brunzell, 2008). LDL-c particles are often termed "bad cholesterol" 
because they have been linked to atheroma formation. On the other hand, high 
concentrations of functional HDL-c, which can remove cholesterol from cells 
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and atheroma, offer protection. These balances are mostly genetically determined 
but can be changed by body build, medications, food choices and other factors 
(Durrington, 2003).  
1.2. Hypolipidemic agents: 
1.2.1. Drugs: 
1.2.1.1. Statins: 
Most current therapeutic approaches seek to lower LDL-c. The discovery 
of statins was a major milestone in lipid lowering therapy. Statins are competitive 
inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, 
the rate limiting enzyme that catalyzes the conversion of HMG CoA to 
mevalonate in the liver cells. Mevalonate is the precursor molecule for 
cholesterol, Coenzymes Q and squalene (an intermediate in cholesterol 
synthesis). The decrease in the intracellular levels of cholesterol induces a higher 
surface expression of LDL receptors which consequently increases the clearance 
of plasma LDL-c. IDL and VLDL remnants are removed as well, contributing to 
lowering triglyceride-rich lipoprotein levels (Anonymous, 2002).  
The new member, Rosuvastatin is reported to be the most potent, reducing 
LDL-c levels by up to 65% (in a dose range of 20-80 mg/day) in clinical studies 
(Olsson, et al., 2001). Statins also have moderate effects on HDL-c, raising levels 
by approximately 5%, and decrease triglyceride concentrations to a maximum of 
about 30% (Vega and Grundy, 1990).   
Unfortunately, the mechanism of action of statins through inhibition of the 
mevalonate pathway inhibits the biosynthesis of vital biochemical products of 
this loop, including coenzyme Q10 (CoQ10). In humans, CoQ10 or ubiquinone 
(2,3-dimethoxy-5- methyl-6-decaprenyl-1,4-benzoquinone) is a major participant 
in electron transfer during oxidative phosphorylation in the mitochondria, a 
potent antioxidant and free radical scavenger, and a membrane stabilizer that 
preserves cellular integrity. These functions are particularly relevant to 
cardiovascular health, leading to the logical conclusion that patients on long-term 
statin therapy should receive supplemental CoQ10 (Bliznakov, 2002). 
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Besides statins, other current lipid-altering agents that lower LDL-c 
primarily through increased hepatic LDL receptor activity include bile acid 
sequestrants / resins and cholesterol absorption inhibitors such as ezetimibe. 
Natural approaches such as plant stanols/sterols, polyphenols, as well as 
nutraceuticals such as oat bran, psyllium and soy proteins are also reported to 
lower LDL-c (Bays and Stein, 2003). 
1.2.2. Plants: 
A plant-based diet that is rich in fruit, vegetables, legumes and low in 
saturated fat, along with regular aerobic exercise program, is a typical 
prescription for anyone with elevated risk of cardiovascular disease. In addition, 
there are a few herbs available that provide some help for persons with 
hyperlipidemia (Winston, 1999). 
1.2.2.1. Sunflower seeds: 
Rats fed the sunflower seed protein fraction showed a similar body weight 
gain and food efficiency ratio as rats fed casein. However, the different dietary 
proteins had different effects on plasma total cholesterol and triglyceride 
contents. The rats fed the sunflower seed protein fraction showed a significant 
decrease in plasma cholesterol (p < 0.02) and triglyceride (p < 0.02) 
concentrations compared to the casein-fed rats. These results demonstrated the 
hypolipidemic action of the sunflower seed protein fraction and that it can be 
considered as a suitable edible protein like casein.  This study and others 
established an inverse relationship between quantity of dietary protein and blood 
cholesterol. This relationship suggests that cholesterol metabolism may depend 
on adequate protein or that cholesterol synthesis is accelerated in protein 
deficiency (Sen and Bhattacharyya, 2001). 
1.2.2.2. Green tea: 
Several epidemiologic studies have suggested that drinking either green or 
black tea may lower blood cholesterol concentrations and blood pressure, thereby 
providing some protection against cardiovascular disease.  When rats were fed 
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green tea polyphones, blood cholesterol concentrations declined in 
hypercholesterolemic animals and blood pressure decreased in spontaneously 
hypertensive animals (Dreosti, 1996). Potential mechanisms include reduced 
micellar solubility and intestinal absorption of cholesterol increased fecal 
excretion of fat and cholesterol, reduced hepatic cholesterol concentration and 
up-regulation of the LDL receptor in liver cells (Bursill,. et al,.2001). 
1.2.2.3. Coriandrum sativum: 
 In the biphasic model of triton-induced hyperlipidemia, Coriandrum 
sativum at a dose of 1g/kg body weight (Bwt) reduced cholesterol and 
triglycerides levels in both synthesis and excretory phases in rats, and the results 
were comparable with that of Liponil, a commercially available herbal 
hypolipidemic drug. The results suggest that coriander decreases the uptake and 
enhances the breakdown of lipids (Lal et al., 2004). The administration of 8% of 
Coriandrum sativum fruits to Wistar albino rats resulted in a significant reduction 
of total and LDL-c levels whereas the level of HDL-c were reported to be 
significantly elevated. These findings are   due to the high fiber and unsaturated/ 
saturated fatty acids ratio content of the fruits (Shihab Eldin, 2007).     
1.2.2.4. Nigella sativa: 
Nigella sativa-treated rats had lower fasting plasma levels of cholesterol 
and triglycerides, and higher HDL-c as compared to pair-fed controls. The 
hypocholesterolemic function of Nigella sativa is either by reducing the synthesis 
of cholesterol by hepatocytes or by decreasing its fractional reabsorption from 
the small intestine (Ali et al., 2004).  
1.2.2.5. Gum Arabic: 
Gum Arabic is a water-soluble non-starch polysaccharides, and as such 
belongs to a group of compounds known to have the potential to lower plasma 
cholesterol in humans and to be fermented by the large bowel micro-flora 
(Topping, 1992). How gum arabic lowers plasma lipids is still unclear, but the 
mechanism is related possibly to increased fecal bile acid and neutral sterol 
excretion or a modification of lipid digestion and absorption (Eastwood, 1992). 
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1.2.2.6. Garlic (Allium sativum L.): 
The administration of 4% and 8% of fresh crushed garlic bulbs to Wistar 
albino rats resulted in a significant reduction of total, LDL-c and triacylglycerol 
levels whereas the level of HDL-c were reported to be significantly elevated. 
(Maha, 2006). Regular use of garlic can be effective in reducing the risk of heart 
attack and stroke because it lowers total and LDL-c and triacylglycerol 
concentrations without affecting HDL-c concentrations (Warshafsky et al., 
1993). Garlic is reported to decrease serum cholesterol, LDL-c and triglycerides, 
possibly through inhibition of HMG-CoA reductase activity and increases the 
excretion of cholesterol as bile acids (Kleijnen et al., 1989).  
1.2.2.7.  flaxseed (Linum usitatissimum): 
Flour derived from flaxseed (Linum usitatissimum) is popular for use in 
bread and bakery products. It provides a nutty flavor and also increases the 
nutritional and health benefits of the final product. Flaxseed consumption may 
lower both total- and LDL-c concentrations because of its low–saturated fat 
content, high polyunsaturated fat, phytosterol content and mucilage content 
(Cunnane et al., 1993). 
1.2.2.8. Cinnamon: 
Cinnamon significantly reduced the triglycerides levels in diabetic 
individuals. This effect of cinnamon is particularly important for hyperlipidemic 
individuals. The lipid lowering effect of cinnamon might be due to insulin 
potentiating action of cinnamon. Usually, when glucose metabolism is improved, 
lipid metabolism is also improved. Some constituents of cinnamon are blocking 
the synthesis of cholesterol or facilitating the clearance of cholesterol from the 
body. The insulin potentiating property of cinnamon may help to reduce 
cholesterol level. High fibers amount present in cinnamon decrease fat absorption 
by the gut resulting in a decrease level of triglycerides in the blood (Alam et al., 
2003). 
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1.2.2.9. Zingiber officinale Roscoe: 
In rabbits fed high cholesterol diets, ginger extracts had antilipemic 
effects, reducing atherogenesis and high lipid levels (Bhandari et al., 1998). 
However, in hypercholesterolemic rats, the data on ginger’s effects has been 
conflicting. Some studies reported positive effects and others found no effects 
(Sambaiah and Srinivasan, 1991). In experimental mice, ginger significantly 
impaired cholesterol biosynthesis and lowered serum cholesterol concentrations 
(Tanabe et al., 1993). 
1.2.2.10. Trigonella foenum graecum (fenugreek): 
The seeds of Trigonella foenum graecum (fenugreek) have been reported 
to have antidiabetic and hypocholesterolaemic properties in both animal models 
and humans (Hannan et al., 2003) Activity has been attributed largely to 
fenugreek’s saponin and high fiber and unsaturated/ saturated fatty acid ratio 
contents of the seeds, and is probably not related to its major alkaloid 
trigonelline. Fenugreek administration may increase plasma insulin levels in 
vivo. The hypocholesterolaemic effect has been attributed to the increased 
conversion of hepatic cholesterol to bile salts which are lost in the faces together 
with fenugreek fiber and saponins. Fenugreek treatment selectively reduces the 
LDL-c and increases HDL-c (Molham and Amala, 1998).  
1.2.3. Fibers: 
Fibrates (including bezafibrate, gemfibrozil and fenofibrate) are a group of 
lipid lowering drugs that have been in existence for over 40 years. They are 
usually used in patients with mixed or combined hyperlipidemia and 
hypertriglyceridemias (Winston, 1999). Fibrates are reported to decrease plasma 
triglycerides by decreasing their hepatic synthesis and increasing their 
catabolism. They decrease the triglyceride- VLDL synthesis through enhancing 
beta-oxidation of fatty acids in the liver and increase the plasma triglycerides 
catabolism by inducing lipoprotein lipase gene transcription and decreasing the 
apoC-III gene transcription. Fibrates are reported to increase HDL-c by 
increasing apoA-I and apoA-II gene transcription (Duriez, 2003). 
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1.3 General taxonomy of Trigonella foenum-graecum: 
Vernacular name (Ar): Hulabah 
1.3.1 Scientific classification: 
Kingdom:  planate 
Division:    Magnoliophyta 
Class:         Magnoliopsida 
Order:        Fabales 
Family:       Fabaceae 
Genus:       Trigonela 
Species:     T. foenum-graecum  
1.3.2 Folkloric uses of fenugreek:  
Fenugreek (Trigonella foenum graecum L.) is one of the oldest medicinal 
plants, originating in India and Northern Africa. An annual plant, fenugreek 
grows to an average height of two feet. The leaves and seeds, which mature in 
long pods, are used to prepare extracts or powders for medicinal use. 
Applications of fenugreek were documented in ancient Egypt where it was used 
in incense and to embalm mummies. In modern Egypt, fenugreek is still used as a 
supplement in wheat and maize flour for bread-making (Morcos et al., 1981). In 
ancient Rome, fenugreek was purportedly used to aid labor and delivery. In 
traditional Chinese medicine, fenugreek seeds are used as a tonic, as well as a 
treatment for weakness and edema of the legs (Yoshikawa et al., 1997). In India, 
fenugreek is commonly consumed as a condiment and used medicinally as a 
lactation stimulant. There are numerous other folkloric uses of fenugreek, 
including the treatment of indigestion and baldness. (Patil et al., 1997). 
1.3.3 Chemical composition of Fenugreek:  
Chemical analysis of fenugreek indicates that the seeds are a rich source 
of protein, unavailable carbohydrate, mucilages and saponins (El-Mahdy and El-
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Sebaiy, 1985). Fenugreek resembles guar gum in its high dietary fibre content, 
and its high viscosity (Valette et al., 1984). Fenugreek seeds are also rich in 
saponins (Sharma, 1986). Anis and Aminuddin. (1985) reported the presence of 
three steroidal sapogenins, diosgenin, gitogenin and tigogenin. The use of more 
sophisticated analytical techniques including coupled GC-MS have detected and 
identified ten different sapogenins (Brenac and Sauvaire, 1996). The presence of 
a sapogenin peptide ester, fenugreekine has been reported (Ghosal et al., 1974). 
Some of the biological properties of the purified steroid saponins have been 
evaluated (Sauvaire et al., 1996) and include hypocholesterolaemic and 
antifungal activity as well as effects on food intake, feeding behavior and 
motivation in rats (Petit et al., 1995). Except for differences in fat and saponin 
content, fenugreek seed powder and the defatted fenugreek are chemically 
similar, containing almost equal amounts of amino acids, minerals and vitamins. 
Fenugreek, like other legumes, is rich in arginine, alanine and glycine; but poor 
in lysine content (Sharma, 1984).  
In the seeds like other legumes, the protein is deficient in methionine. 
Trigonelline is an important alkaloidal component of the seeds. The seeds contain 
less starch but higher proportions of minerals (Ca, P, Fe, Zn and Mn) compared 
with other grain legumes (Sankara and Deosthale, 1981). The total lipid content 
(7.5%) of the seeds consists of neutral lipids, glycolipids and phospholipids 
(Hemavathy and Prabhakar, 1989). The aromatic constituents of the seeds have 
been elucidated (Girardon et al., 1985) and include n-alkanes, sesquiterpenes and 
some oxygenated compounds such as hexanol and g- nonalactone. The seeds are 
also known to contain flavonoids, carotenoids, coumarins and other components 
(Varshney and Sharma, 1996). 
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CHAPTER TWO 
MATERIAL AND METHODS 
 
2.1. Experimental details: 
This experiment was designed to evaluate the effect of feeding Trigonella 
foenum graecum seed powder (TSP) mixed diet on plasma lipid concentration in 
an induced hypercholesterolemic Wistar albino rats. 
2.1.1. Experimental animals: 
Twenty Wistar albino rats obtained from the National Center for 
Research, Khartoum were used in this study. The rats were housed identically in 
stainless steel cages in an air room under suitable conditions. All of the rats were 
initially fed a standard laboratory diet for at least 7 days to acclimatize to our 
laboratory. Tap water was freely available.  
2.1.2. The rat basal diet: 
The rats were given a basal diet which fulfilled their requirement. The 
composition was as follows: 
Wheat flour              692g 
Dry meat                  165g 
Sodium chloride        3g 
Oil                            120g 
2.2. Plant material:  
The fenugreek seeds was locally purchased, identified and peeled in fine 
pieces then added to the diet. 
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2.3. Cholesterol supplementation in the diet: 
  1% cholesterol powder was supplemented to the basal diet of the rats so as to 
induce hypercholesterolemia in all groups except the control group, according to 
(Sharma, 1984). 
2.4. Equipment used: 
• Heparinized capillary tubes. 
• Heparinized blood containers. 
• Plane containers. 
• Centrifuge. 
• Automatic pipettes. 
• Roche diagnostic/Hitachi 902 analyzer. 
2.4.1. Chemicals: 
• Cholesterol powder. 
2.5. Experimental procedure: 
The animals were divided into four groups of five animals each. These 
groups were named as A, B, C, and D. Group A was given the basal diet and 
served as control, group B received 1% cholesterol added to the basal diet. Group 
C received 1% cholesterol and 4% Trigonella foenum graecum seed powder TSP 
added to the basal diet, Group D received 1% cholesterol and 8% TSP added to 
the basal diet. Blood samples were collected after two weeks following treatment 
so as to confirm the induction of hypercholesterolemia. Then after another two 
weeks the blood samples were taken for the determination of lipid fractions 
concentration. 
2.5.1. Blood sampling: 
1.5 ml of blood was collected from the rats orbital plexus after an 
overnight fast by capillary tubes and was put in heparinized containers; the blood 
was centrifuged at 5000 rpm for 10 minutes. Then the plasma was placed into 
plane containers and used immediately. 
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2.6. Analytical methods: 
2.6.1. Roche diagnostic/Hitachi 902 analyzer: 
All lipid fractions were estimated using the Roche diagnostic Hitachi 902 
analyzer. It is an analyzer to report test results on various body fluid samples for 
wide range of analysis. It is fully automated, computerized, performs 
potentiometric and photometric assays, and includes analytical processing unit 
and luminance crystal display (LCD) touch screen, with a standard printer to 
print the results. The analyzer is characterized by doing 200 photometric tests/ 
hour, and refrigerated storage for 40 reagent containers, as well as it has end 
point, and kinetic and isoenzymes reactions. 
2.6.2. Total cholesterol estimation: 
Principle: 
In the presence of cholesterol esterase, the cholesterol esters in the sample 
are hydrolyzed to cholesterol and free fatty acids. The cholesterol produced is 
oxidized by cholesterol oxidase to cholesterol and hydrogen peroxide. Hydrogen 
peroxide is detected by chromogenic oxygen acceptor, phenol – ampyrone, in the 
presence of peroxidase. The red quinine formed is proportional to the amount of 
cholesterol present in the sample.  
Reagents and linearity: 
Reagent (1)   buffer pH 6.9                                 90 mmol/L 
                    Phenol                                              26 mmol/L 
Reagent (2)  Cholesterol esterase                        300 U/L 
                     Cholesterol oxidase                        300 U/L 
                     Phenol- ampyrone/ peroxidase       1250 U/L 
                     4 – Aminoantipyrine                      0.4 mmol/L  
Linearity range: This method is linear up to 600 mg/dl             
Procedure: 
The analyzer automatically adds an equal quantity from sample, R1 and R2 
to the reaction. 
Calculations: 
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The analyzer automatically calculates the analyte concentration of each 
sample. The result will appear directly on the screen of the diagnostic machine at 
the end of the reaction between the reagents and samples. 
2.6.3. Low density lipoprotein-cholesterol (LDL-c) estimation: 
Principle: 
LDL-c particles in the sample are precipitated with polyvinyl sulphate. 
Their concentration is calculated from the difference between the serum total 
cholesterol and the cholesterol in the suprnatant after centrifugation. The 
cholesterol is spectrophometrically measured by means of the coupled reactions 
as described for cholesterol.  
Reagents and linearity: 
Reagent (1): polyvinyl sulphate 3g/L, polyethylene glycol 3g/L. 
Procedure:  
The analyzer automatically adds an equal quantity from sample and 
reagents to the reaction. 
Calculations: 
The analyzer automatically calculates the analyte concentration of each 
sample. The result will appear directly on the screen of the diagnostic machine at 
the end of the reaction between the reagents and samples. 
2.6.4. High density lipoprotein-cholesterol (HDL-c) estimation: 
Principle: 
Very low density lipoproteins (VLDL) and low density lipoproteins 
(LDL) in the sample are precipitated with phosphotungstate and magnesium ions. 
The supernatant contains HDL-c. The HDL-c is then spectrophotometrically 
measured by means of coupled reactions described for cholesterol.  
Reagents: 
Reagent (B). 50 ml phosphotungstate (0.4 m mol/L) and magnesium 
(chloride 20 m mol/L). 
HDL-c standard concentration = 40 mg/dl. 
Linear Range: this method is linear up to 600 mg/dl. 
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Procedure: 
The analyzer automatically adds an equal quantity from the sample and 
reagents to the reaction. 
Calculations: 
The analyzer automatically calculates the analyte concentration of each 
sample. The result will appear directly on the screen of the diagnostic machine at 
the end of the reaction between the reagents and samples. 
2.6.5. Triglycerides estimation: 
Principle: 
Triglycerides in the sample are hydrolyzed enzymatically to glycerol and 
fatty acids. The glycerol formed is converted to glycerol phosphate by glycerol 
kinase. Glycerol phosphate is oxidized to dihydroxyacetone phosphate by 
glycerol phosphate oxidase. The liberated hydrogen peroxide is detected by a 
chromogenic acceptor, chlorophenol and 4-amino antipyrine in the presence of 
peroxidase. The red quinone formed is proportional to the amount of triglyceride 
present in the sample.  
Reagents and linearity: 
  Reagent (1)     Buffer                                                   45 mmol/L 
                          Chlorophenol                                        6 mmol/L  
  Reagent (2)     Magnesium chloride                              5 mmol/L 
                          Lipase                                                  >100 u/ MI 
                          Glycerol kinase                                    >1.5 u/mL 
                          Glycerol -3- oxidase phosphate           >4 u/ mL 
                                  Peroxidase                                           >0.8 u/mL                                            
                                  4- aminoantipyrine                                 0.75 mmol/L 
                          ATP                                                        0.9 mmol/L 
                           PH                                                          7.5 
Linearity range: This method is linear up to 600 mg/dl. 
Procedure: 
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The analyzer automatically adds an equal quantity from sample, R1 and R2 
to the reaction. 
 
 
Calculations: 
The analyzer automatically calculates the analyte concentration of each 
sample. The result will appear directly on the screen of the diagnostic machine at 
the end of the reaction between the reagents and samples. 
Quality Control: 
The precision and accuracy of all methods used in this study were checked 
each time a batch was analyzed by including commercially prepared control sera. 
2.6.6. Statistical analysis: 
Results were analyzed using SPSS version 11 analysis of variances one 
way ANOVA. The significance was determined at 5% level by using the t-test. 
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CHAPTER THREE 
RESULTS 
3.1. The induction of hypercholesterolemia: 
There is a significant increase in the total cholesterol level as well as 
LDL-c, and a significant decrease in HDL-c in group B compared to the control 
group. These results confirm the induction of hypercholesterolemia in group B as 
shown in table (1) and Fig. (1, 2 and 3). 
 
Table (1):  The levels of total cholesterol, LDL-c and HDL-c in group B 
compared to group A two weeks after supplementation of 1% 
cholesterol. 
 
     Parameters 
G       Groups 
T-cholesterol (mg/dl)
H 
HDL-c  (mg/dl) LDL-c (mg/dl) 
      A    66.00±9.71a   12.58±3.99a  50.24±7.95a 
     
      B    124.60±8.17b   58.34±  5.68b  38.20±3.56b 
 
Means ± SE within the same column having different superscript small 
letters are significantly different at (P < 0.05) based on t- test. 
 
 
Group A: Fed basal diet and served as control. 
 
Group B: Fed 1% cholesterol mixed with the basal diet.   
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Fig. (1): The level of total cholesterol in group B compared to group A two 
weeks after supplementation of 1% cholesterol. 
 
Bars having different superscript small letters are significantly different at 
(P < 0.05) based on t- test. 
 
 
Group A: Fed basal diet and served as control. 
 
Group B: Fed 1% cholesterol mixed with the basal diet.   
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Fig. (2): The level of LDL-c in group B compared to group A two weeks after 
supplementation of 1% cholesterol. 
 
Bars having different superscript small letters are significantly different at 
(P < 0.05) based on t- test. 
 
Group A: Fed basal diet and served as control. 
 
Group B: Fed 1% cholesterol mixed with the basal diet.   
 22 
 
Fig. (3): The level of HDL-c in group B compared to group A two weeks 
after supplementation of 1% cholesterol. 
 
 
Bars having different superscript small letters are significantly different at 
(P < 0.05) based on t- test. 
 
Group A: Fed basal diet and served as control. 
 
Group B: Fed 1% cholesterol mixed with the basal diet.   
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3.2. The effect of feeding fenugreek seeds powder on plasma total         
cholesterol level in an induced hypercholesterolemic Wistar albino rats: 
 Table (2) and Fig. (4) show the results of plasma total cholesterol of group A, 
B, C and D. The level of plasma total cholesterol in group B is significantly (P< 
0.05) higher than the levels of plasma total cholesterol in group A, C and D. in 
group C the level of plasma total cholesterol is non-significantly higher than that 
of group A and group D, and significantly (P < 0.05) lower than the level of 
plasma total cholesterol in group B. However, in group D the level of plasma 
total cholesterol is significantly (P < 0.05) lower than the level of plasma total 
cholesterol in group B but non- significantly different form group A and group C. 
3.3. The effect of feeding fenugreek seeds powder on plasma LDL-c level in 
an induced hypercholesterolemic Wistar albino rats: 
Table (2) and Fig. (5) show the results of plasma LDL- c of group A, B, C 
and D. The level of plasma LDL-c in group B is significantly (P< 0.05) higher 
than the levels of plasma LDL-c in group A, C and D. in group C the level of 
plasma LDL-c is non-significantly different compared to the levels of plasma 
LDL-c of group A and group D, and significantly (P < 0.05) lower than the level 
of plasma LDL-c in group B. However, in group D the level of plasma LDL-c is 
significantly (P < 0.05) lower than the level of plasma LDL-c in group B but 
non- significantly different form groups A and group C. 
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Table (2): The effect of feeding fenugreek seeds powder on plasma total 
cholesterol, low density lipoprotein-cholesterol, high density 
lipoprotein-cholesterol and triglycerides level in an induced 
hypercholesterolemic Wister albino rats: 
   Parameters 
Groups 
T-cholesterol (mg/ dl)  HDL-c (mg/dl) LDL-c (mg/dl)  Triglycerides (mg/dl)
    A  84.00  ±1.87
a 2.58±3.99a 52.60±6.45a 86.00±3.48a 
    B 121.67±11.59
b 58.34±5.68b 38.40±2.00b 86.25 ±6.31a 
    C 91.41±3.10
a 20.60±1.28a 57.40±5.27a 83.33 ±2.02a 
    D 90.25±3.47
a 23.28±2.99a 57.38±2.27a 70.67 ±9.17a 
 
Means ± SE within the same column having different superscript small 
letters are significantly different at (P < 0.05) based on t- test. 
 
 
Group A: fed basal diet. 
Group B: fed 1% cholesterol basal diet. 
Group C: fed 1% cholesterol and 4% TSP added to the basal diet. 
Group D: fed 1% cholesterol and 8% TSP added to the basal diet.  
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Fig. (4): The effect of feeding fenugreek seeds powder on plasma level of 
total cholesterol in an induced hypercholesterolemic Wistar albino 
rats. 
 
Bars having different superscript small letters are significantly different at 
(P < 0.05) based on t- test. 
 
Group A: Fed basal diet. 
Group B: Fed 1% cholesterol basal added to the diet. 
Group C: Fed 1% cholesterol and 4% TSP added to the basal diet. 
Group D: Fed 1% cholesterol and 8% TSP added to the basal diet. 
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Fig. (5): The effect of feeding fenugreek seeds powder on plasma level of 
LDL-c in an induced hypercholesterolemic Wistar albino rats. 
 
Bars having different superscript small letters are significantly different at 
(P < 0.05) based on t- test. 
 
 
Group A: Fed basal added diet. 
Group B: Fed 1% cholesterol added the basal diet. 
Group C: Fed 1% cholesterol and 4% TSP added to the basal diet. 
Group D: Fed 1% cholesterol and 8% TSP added to the basal diet.  
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3.4 The effect of feeding fenugreek seeds powder on plasma HDL-c level in 
an induced hypercholesterolemic Wistar albino rats: 
Table (2) and Fig. (6) show the results of plasma HDL-c of groups A, B, C 
and D. The level of plasma HDL-c in group B is significantly (P< 0.05) lower 
than the levels of plasma HDL-c in group A, C and D. In group C the level of 
plasma HDL-c is non-significantly different compared to the levels of plasma 
HDL-c of group A and group D, and significantly (P < 0.05) higher than the level 
of plasma HDL-c in group B. However, in group D the level of plasma HDL-c is 
significantly (P < 0.05) lower than the level of plasma HDL-c in group B but 
non- significantly different form group A and group C. 
3.5 The effect of feeding fenugreek seeds powder on plasma                             
triglycerides level in an induced hypercholesterolemic Wistar albino rats: 
Table (2) and Fig. (7) show the results of plasma triglycerides level of 
group A, B, C and D. The level of plasma triglycerides in group B is non-
significantly higher than the levels of plasma triglycerides in group A, C and D. 
in group C the level of plasma triglycerides is non-significantly lower than the 
levels of plasma triglycerides of group A and group B, and non-significantly 
higher than the level of plasma triglycerides in group D. However, in group D the 
level of plasma triglycerides is non-significantly lower than the level of plasma 
triglycerides in group A, B, and C.  
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Fig. (6): The effect of feeding fenugreek seeds powder on plasma level of 
HDL-c in an induced hypercholesterolemic Wistar albino rats. 
 
Bras having different superscript small letters are significantly different at 
(P < 0.05) based on t- test. 
 
 
Group A: fed basal diet. 
Group B: fed 1% cholesterol added to the basal diet. 
Group C: fed 1% cholesterol and 4% TSP added to the basal diet. 
Group D: fed 1% cholesterol and 8% TSP added to the basal diet. 
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Fig. (7): The effect of feeding fenugreek seeds powder on plasma level of 
triglycerides in an induced hypercholesterolemia Wistar albino rats.   
 
Bars having different superscript small letters are significantly different at 
(P < 0.05) based on t- test. 
 
 
Group A: fed basal diet. 
Group B: fed 1% cholesterol added to the basal diet. 
Group C: fed 1% cholesterol and 4% TSP added to the basal diet. 
Group D: fed 1% cholesterol and 8% TSP added to the basal diet.  
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CHAPTER FOUR 
DISSCUSION 
 
This study was carried out to evaluate the effect of feeding Trigonella 
foenum graecum seeds powder (TSP) on plasma levels of total cholesterol, low 
density lipoprotein-cholesterol (LDL-c), high density lipoprotein-cholesterol 
(HDL-c) and triglycerides in an induced hypercholesterolemic Wistar albino rats. 
4.1 Induction of hypercholesterolemia:  
The results showed that the plasma total cholesterol and LDL-c levels 
were significantly increased (P< 0.05) following administration of 1% 
cholesterol powder mixed with the basal diet after two weeks in group B 
compared to group A (control), but there was a significant (P< 0.05) decrease in 
HDL-c level. These results were in agreement with the study of Sharma (1984), 
who reported that administration of 1% cholesterol powder resulted in an 
increase total and LDL-c, but the HDL-c was reported to be decreased. Also the 
results were in line with the result obtained by Shela et al. (2005) who reported 
that administration of 1% cholesterol powder to rabbits resulted in an increase 
total and LDL-c, but the HDL-c was reported to be decreased. 
4.2 The effect of feeding fenugreek seeds powder on the levels of: 
4.2.1 Plasma total cholesterol:  
The level of plasma total cholesterol was decreased significantly (P<0.05) 
after the administration of 4% and 8% TSP compared to the control. These 
results were in line with those obtained by Yadav et al. (2004) who reported that 
feeding 5% of TSP mixed with the powdered rat feed for 21 days resulted in a 
significant reduction of serum total cholesterol, this is may be due to  the high 
fiber content of TSP. The results were also in line with the results stated by 
Molham and Amala (1998), who reported that feeding of 50% TSP mixed diet 
for two weeks to hypercholesterolemic rats resulted in a reduction of Plasma total 
cholesterol, which is attributed to an increased conversion of hepatic cholesterol 
to bile salts which is lost in the faces together with fenugreek fiber and saponins. 
Also the TSP improves insulin secretion, which has an inhibitory action on 
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HMG-CoA reductase, a key rate limiting enzyme responsible for the synthesis of 
cholesterol (Petit et al., 1995).  
Hannan et al. (2003) reported that the administration of the soluble dietary 
fiber (SDF) fraction of Trigonella foenum graecum (Tf-sdf) to rats orally twice 
daily at a dose of 0.5 g kg⎯1 for 28 days lowered the serum cholesterol level. Tf-
sdf fraction effectively inhibits fats absorption in the gut (Madar and Shomer, 
1990). Therefore, the hypolipidemic action of the soluble fraction could be as a 
result of impairment of fats absorption due to the presence of high amounts of 
fiber in the seeds. 
According to the above mentioned results the hypocholesterolaemic effect 
of TSP may be due to impairment of fats absorption due to the presence of fiber 
in the seeds and increased conversion of hepatic cholesterol to bile salts which is 
lost in the faces together with fenugreek fiber and saponins. Also the 
hypocholesterolemic effect of TSP may be due to the improvement of insulin 
secretion because insulin has an inhibitory action on HMG-CoA reductase, a key 
rate limiting enzyme responsible for the synthesis of cholesterol. 
4.2.2 Plasma LDL-c: 
The level of Plasma LDL-c decreased significantly (P<0.05) after the 
administration of 4% and 8% TSP. These results were in line with the results 
stated by Molham and Amala (1998), who reported that feeding of 50% TSP 
mixed diet for two weeks to hypercholesterolemic rats resulted in a reduction of 
Plasma LDL-c, which may be due to the high fiber and saponins contents of the 
TSP. Hwang et al. (2001) reported that feeding of 5% sativum whole fruits to rats 
after high fat diet decreased LDL-c level significantly due to the fiber content 
that increases LDL-c receptor activity. 
The results were also agreement with those obtained by Sharma et al. 
(1996) who reported that feeding 10% TSP mixed with rats basal diet for two 
weeks resulted in a significant decrease of plasma LDL-c level which is 
explained to be due to the  high fiber content of the seeds. 
From the above mentioned results the reduction of LDL-c level by TSP is 
due to the high fiber and saponins contents of the TSP which increases LDL-c 
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receptors activity that enhance the uptake of LDL-c particles by cells. Also the 
fiber and saponins contents of the TSP reduce the release of LDL-c particles 
from the hepatocytes.  
 4.2.3 Plasma HDL-c: 
In the present study addition of 4% and 8% of TSP to the basal diet of an 
induced hypercholesterolemic Wistar albino rats resulted in a significant increase 
of Plasma HDL-c. These results agree with the results stated by Molham and 
Amala (1998), who reported that feeding of 50% TSP mixed diet for two weeks 
to hypercholesterolemic rats resulted in the elevation of Plasma HDL-c level, 
which is attributed to the high fiber and unsaturated/ saturated fatty acids ratio 
contents of the seeds. 
Hannan et al. (2003) reported that the administration of the soluble dietary 
fiber (SDF) fraction of Trigonella foenum graecum (Tf-sdf) to rats orally twice 
daily at a dose of 0.5 g kg ⎯1 for 28 days increased the serum HDL-c level. Tf-sdf 
fraction effectively inhibits fat absorption due to the presence of high fiber 
concentration in the seeds this lead to decrease VLDL production and increase 
HDL-c level. 
According to the above mentioned findings the elevated level of HDL-c is 
attributed to the high fiber and unsaturated/ saturated fatty acids ratio contents of 
the seeds which decrease VLDL and increase HDL-c production. 
4.2.4 Plasma triglycerides: 
In the present study addition of 4% and 8% of TSP to the basal diet of an 
induced hypercholesterolemic Wistar albino rats resulted in a non significant 
decease of plasma triglycerides level. These findings were in line with Sowmya 
and Rajyalakshmi (1999), who observed a non- significant reduction in plasma 
triglycerides level in 20 adult individuals with hypercholesterolemia who 
received 12.5-18.0 g powdered fenugreek seeds for one month. But these results 
disagree with Alam et al. (2003) who concluded that feeding of 1g, 3g and 6g 
cinnamon (contain the same hypolipidemic agents that present in fenugreek ) per 
day to type 2 diabetic individuals for 60 days reduced significantly triglycerides 
concentration. This may be due to the short duration of this experiment.   
 33 
 
From the above mentioned findings the TSP may need more than one 
month to display it's hypotriglceridemic effect.  
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CONCLUSION: 
The results indicated that mixing of Trigonella foenum graecum seeds 
powder (TSP) with diet significantly reduced atherogenic lipids in Wistar albino 
rats when given at doses of 4% and 8% for one month.    
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